237 related articles for article (PubMed ID: 21318450)
1. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
Brancato SC; Arrighi JA
J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
[No Abstract] [Full Text] [Related]
2. Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.
Martineau P; Pelletier-Galarneau M; Juneau D; Leung E; Nery PB; de Kemp R; Beanlands R; Birnie D
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2280-2281. PubMed ID: 31422126
[No Abstract] [Full Text] [Related]
3. Advances in radionuclide imaging of cardiac sarcoidosis.
Kouranos V; Wells AU; Sharma R; Underwood SR; Wechalekar K
Br Med Bull; 2015 Sep; 115(1):151-63. PubMed ID: 26311504
[TBL] [Abstract][Full Text] [Related]
4. PET/CT Evaluation of Cardiac Sarcoidosis.
Bois JP; Muser D; Chareonthaitawee P
PET Clin; 2019 Apr; 14(2):223-232. PubMed ID: 30826020
[TBL] [Abstract][Full Text] [Related]
5. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
Campisi R; Merani MF; Rodríguez MI
Curr Cardiol Rep; 2022 Dec; 24(12):1873-1882. PubMed ID: 36282434
[TBL] [Abstract][Full Text] [Related]
7. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
[TBL] [Abstract][Full Text] [Related]
8. Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
Isiguzo M; Brunken R; Tchou P; Xu M; Culver DA
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):50-5. PubMed ID: 21796891
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker.
Smedema JP; White L; Klopper AJ
Cardiovasc J Afr; 2008; 19(6):309-10. PubMed ID: 19104727
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide Assessment of Sarcoidosis.
Divakaran S
Cardiol Clin; 2023 May; 41(2):207-215. PubMed ID: 37003678
[TBL] [Abstract][Full Text] [Related]
12. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
13. PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
Manapragada PP; Andrikopoulou E; Bajaj N; Bhambhvani P
Radiol Clin North Am; 2021 Sep; 59(5):835-852. PubMed ID: 34392922
[TBL] [Abstract][Full Text] [Related]
14. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET.
Yamamoto A; Nagao M; Watanabe E; Imamura Y; Suzuki A; Fukushima K; Ando K; Nakao R; Sakai A; Momose M; Sakai S; Hagiwara N
J Nucl Cardiol; 2021 Jun; 28(3):919-929. PubMed ID: 33728571
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.
Györik S; Ceriani L; Menafoglio A; Gallino A; Wyttenbach R
Thorax; 2007 Jun; 62(6):560. PubMed ID: 17536038
[No Abstract] [Full Text] [Related]
17. Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential
Ostwani W; Hanna C; Brice AE; Wymer DC
J Nucl Med Technol; 2020 Dec; 48(4):378-380. PubMed ID: 32518122
[TBL] [Abstract][Full Text] [Related]
18. False-positive (13)N-ammonia/(18)FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis.
Gonzalez WO; Massera D; Travin MI
J Nucl Cardiol; 2015 Dec; 22(6):1323-5. PubMed ID: 25762035
[No Abstract] [Full Text] [Related]
19. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
[No Abstract] [Full Text] [Related]
20. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
